SpringWorks Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
SpringWorks Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2018 to 2023.
  • SpringWorks Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $26.2M, a 14.2% increase year-over-year.
  • SpringWorks Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $105M, a 25.1% increase year-over-year.
  • SpringWorks Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $94.5M, a 29.6% increase from 2022.
  • SpringWorks Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $73M, a 89.8% increase from 2021.
  • SpringWorks Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $38.4M, a 283% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $94.5M +$21.6M +29.6% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 $73M +$34.5M +89.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 $38.4M +$28.4M +283% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
2020 $10M +$6.93M +223% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $3.11M +$2.04M +191% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 $1.07M Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.